The Sidney Kimmel Comprehensive Cancer Center
- Country
- 🇺🇸United States
- Ownership
- Private, Subsidiary
- Employees
- -
- Market Cap
- -
NC410 and FOLFIRINOX in Combination With Nivolumab With or Without Ipilimumab in Patients With Untreated Metastatic Pancreatic Cancer
- Conditions
- Pancreatic Cancer
- Interventions
- First Posted Date
- 2025-04-24
- Last Posted Date
- 2025-04-24
- Target Recruit Count
- 20
- Registration Number
- NCT06941857
- Locations
- 🇺🇸
Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland, United States
The COSMYC Trial (COmbined Suppression of MYC)
- Conditions
- Metastatic Castration-resistant Prostate Cancer
- Interventions
- Drug: Luteinizing hormone-releasing hormone (LHRH) analogue
- First Posted Date
- 2025-04-10
- Last Posted Date
- 2025-04-10
- Target Recruit Count
- 50
- Registration Number
- NCT06922318
- Locations
- 🇺🇸
Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland, United States
Proton SBRT for Spinal Metastasis
- Conditions
- Spinal Metastasis
- First Posted Date
- 2025-03-26
- Last Posted Date
- 2025-04-30
- Target Recruit Count
- 12
- Registration Number
- NCT06895564
- Locations
- 🇺🇸
Johns Hopkins Hospital, Baltimore, Maryland, United States
Standard-of-Care Reduced-Intensity Conditioning (RIC) With 200 Versus 400 cGy of Total Body Irradiation (TBI) in Patients With Acute Leukemia Undergoing First Allogeneic Blood or Marrow Transplantation (BMT)
- Conditions
- Acute LeukemiaAcute Lymphoblastic Lymphoma
- First Posted Date
- 2025-03-25
- Last Posted Date
- 2025-04-02
- Target Recruit Count
- 160
- Registration Number
- NCT06803745
- Locations
- 🇺🇸
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States
Single Patient Compassionate Use of X-PACT in Salvage Treatment of Prostate Cancer
- Conditions
- Prostate Cancer
- Locations
- 🇺🇸
Kimmel Cancer Center at Johns Hopkins at Sibley Memorial Hospital, Washington, District of Columbia, United States
7-Days Water-Only Fasting Trial in Prostate Cancer
- Conditions
- Metastatic Prostate Cancer
- First Posted Date
- 2025-02-14
- Last Posted Date
- 2025-05-21
- Target Recruit Count
- 10
- Registration Number
- NCT06826924
Targeted Oligometastatic Radiation in Pediatric and Young Adult Patients With Soft Tissue and Bone Sarcoma
- Conditions
- Ewing SarcomaRhabdomyosarcomaMetastatic SarcomaRadiation Therapy Patient
- First Posted Date
- 2025-01-28
- Last Posted Date
- 2025-04-17
- Target Recruit Count
- 70
- Registration Number
- NCT06796543
- Locations
- 🇺🇸
Sibley Memorial Hospital, Washington, District of Columbia, United States
🇺🇸Johns Hopkins Hospital, Baltimore, Maryland, United States
Comparing Neoadjuvant/Adjuvant GVAX vs a mKRASvax Given With Anti-PD-1 and Anti-CD137 for Surgically Resectable Pancreatic Cancer
- Conditions
- Pancreatic Cancer
- Interventions
- First Posted Date
- 2025-01-20
- Last Posted Date
- 2025-04-13
- Target Recruit Count
- 38
- Registration Number
- NCT06782932
- Locations
- 🇺🇸
Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland, United States
Study in Patients With Breast Cancer Leptomeningeal Metastasis
- Conditions
- Leptomeningeal Metastasis of Breast Cancer
- First Posted Date
- 2024-10-15
- Last Posted Date
- 2024-11-27
- Target Recruit Count
- 30
- Registration Number
- NCT06638294
- Locations
- 🇺🇸
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States
Study of Senaparib in Combination With Temozolomide in ARID1A Mutation Associated Ovarian Cancer
- Conditions
- Ovary CancerFallopian Tube CancerPrimary Peritoneal Cavity Cancer
- Interventions
- First Posted Date
- 2024-10-01
- Last Posted Date
- 2025-02-10
- Target Recruit Count
- 18
- Registration Number
- NCT06617923
- Locations
- 🇺🇸
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States